Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Net Cash Flow (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Net Cash Flow for 5 consecutive years, with $32.9 million as the latest value for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 372.91% year-over-year to $32.9 million; the TTM value through Dec 2025 reached $30.1 million, up 376.36%, while the annual FY2025 figure was $30.1 million, 376.36% up from the prior year.
  • Net Cash Flow hit $32.9 million in Q4 2025 for Kezar Life Sciences, up from $4.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $66.5 million in Q2 2022 and bottomed at -$40.9 million in Q3 2022.
  • Average Net Cash Flow over 5 years is $2.5 million, with a median of $51500.0 recorded in 2021.
  • On a YoY basis, Net Cash Flow climbed as much as 1808.32% in 2022 and fell as far as 1519.22% in 2022.
  • Kezar Life Sciences' Net Cash Flow stood at $5.8 million in 2021, then tumbled by 515.59% to -$24.0 million in 2022, then soared by 137.26% to $9.0 million in 2023, then decreased by 22.23% to $7.0 million in 2024, then surged by 372.91% to $32.9 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $32.9 million, $4.6 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.